High expression levels of IL12α have a negative impact on patient survival, irrespective of the mutational status of FTL3 (Supplementary Materials Table S3, Figure 3c) while high IL12α levels resulted in significantly reduced survival in data sets integrating all AML patients. The gene discussed is IL12A; the disease is acute myeloid leukemia.